BNP Paribas Financial Markets’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,611
| Closed | -$4.31M | – | 3484 |
|
|
2023
Q4 | $4.31M | Buy |
13,611
+462
| +4% | +$146K | ﹤0.01% | 1047 |
|
|
2023
Q3 | $2.22M | Buy |
13,149
+6,013
| +84% | +$1.02M | ﹤0.01% | 1308 |
|
|
2023
Q2 | $1.55M | Sell |
7,136
-12,115
| -63% | -$2.63M | ﹤0.01% | 1406 |
|
|
2023
Q1 | $3.5M | Sell |
19,251
-14,820
| -43% | -$2.69M | ﹤0.01% | 1075 |
|
|
2022
Q4 | $6.69M | Sell |
34,071
-18,482
| -35% | -$3.63M | 0.01% | 805 |
|
|
2022
Q3 | $11.8M | Buy |
52,553
+46,702
| +798% | +$10.5M | 0.02% | 616 |
|
|
2022
Q2 | $740K | Buy |
5,851
+3,985
| +214% | +$504K | ﹤0.01% | 1844 |
|
|
2022
Q1 | $237K | Sell |
1,866
-2,827
| -60% | -$358K | ﹤0.01% | 2509 |
|
|
2021
Q4 | $615K | Buy |
4,693
+652
| +16% | +$85.4K | ﹤0.01% | 2300 |
|
|
2021
Q3 | $494K | Buy |
4,041
+1,907
| +89% | +$233K | ﹤0.01% | 2185 |
|
|
2021
Q2 | $243K | Buy |
2,134
+144
| +7% | +$16.4K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $239K | Buy |
1,990
+41
| +2% | +$4.93K | ﹤0.01% | 2410 |
|
|
2020
Q4 | $198K | Sell |
1,949
-1,777
| -48% | -$181K | ﹤0.01% | 2252 |
|
|
2020
Q3 | $288K | Buy |
3,726
+1,852
| +99% | +$143K | ﹤0.01% | 1956 |
|
|
2020
Q2 | $209K | Sell |
1,874
-1,570
| -46% | -$175K | ﹤0.01% | 1868 |
|
|
2020
Q1 | $248K | Buy |
3,444
+2,912
| +547% | +$210K | ﹤0.01% | 2169 |
|
|
2019
Q4 | $40.1K | Sell |
532
-47
| -8% | -$3.54K | ﹤0.01% | 3094 |
|
|
2019
Q3 | $9.45K | Buy |
+579
| New | +$9.45K | ﹤0.01% | 3517 |
|